Merck, Schering-Plough End Vytorin Investigation
In a settlement, Merck & Co. and Schering-Plough Corp. have agreed to reimburse 35 states and the District of Columbia for the costs associated with investigating a delay in the companies'...To view the full article, register now.
Already a subscriber? Click here to view full article